{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:28:39Z","timestamp":1794479319361,"version":"4.9.1"},"reference-count":254,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425\\u201325\\u20131\\u20130419"],"award-info":[{"award-number":["HT9425\\u201325\\u20131\\u20130419"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biopha.2026.119389","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:05:03Z","timestamp":1776668703000},"page":"119389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evolving role of biomarkers in spinal cord injury: From research to clinical translation"],"prefix":"10.1016","volume":"199","author":[{"given":"Syed Suhail","family":"Andrabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-1542","authenticated-orcid":false,"given":"Vinod","family":"Labhasetwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119389_bib1","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1007\/s00586-025-09221-0","article-title":"Global, regional, and National burdens of cervical spinal cord injuries from 1990 to 2021, findings from global burden of disease study 2021","volume":"34","author":"Wang","year":"2025","journal-title":"Eur. Spine J."},{"key":"10.1016\/j.biopha.2026.119389_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10790268.2020.1718469","article-title":"Neurogenic bowel and bladder evaluation strategies in spinal cord injury: new directions","volume":"43","author":"Gater","year":"2020","journal-title":"J. Spinal Cord. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib3","article-title":"Risk factors for lower extremity deep vein thrombosis by spinal cord injury level: a population-based analysis","author":"Pando","year":"2025","journal-title":"Glob. Spine J."},{"key":"10.1016\/j.biopha.2026.119389_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1153432","article-title":"Incidence and risk factors of deep vein thrombosis in patients with spinal cord injury: a systematic review with meta-analysis","volume":"10","author":"Shang","year":"2023","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.biopha.2026.119389_bib5","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.4103\/1673-5374.339475","article-title":"Spinal cord injury-induced cognitive impairment: a narrative review","volume":"17","author":"Alc\u00e1ntar-Garibay","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119389_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1186\/s13018-025-05985-9","article-title":"Global epidemiological trends and burden of cervical and subcervical spinal cord injuries, 1990-2021: a multidimensional analysis using global burden of disease data","volume":"20","author":"Liu","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.biopha.2026.119389_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237197","article-title":"Neurogenic aging after spinal cord injury: highlighting the unique characteristics of aging after spinal cord injury","volume":"13","author":"Tretter","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib8","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/nature16035","article-title":"Global neurotrauma research challenges and opportunities","volume":"527","author":"Rubiano","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119389_bib9","article-title":"Perspective of the world rehabilitation alliance: global strategies to strengthen spinal cord injury rehabilitation services in health systems","volume":"12","author":"O'Connell","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.biopha.2026.119389_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/14737175.2023.2215429","article-title":"Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?","volume":"23","author":"Wong","year":"2023","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.biopha.2026.119389_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s13311-018-0630-7","article-title":"Glial cells shape pathology and repair after spinal cord injury","volume":"15","author":"Gaudet","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119389_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.09.017","article-title":"Neurovascular dynamics in the spinal cord from development to pathophysiology","author":"Ruiz de Almodovar","year":"2025","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119389_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.31083\/j.jin2206153","article-title":"Targeting mitochondrial oxidative stress: potential neuroprotective therapy for spinal cord injury","volume":"22","author":"He","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib14","article-title":"The role of oxidative stress in spinal cord ischemia reperfusion injury: mechanisms and therapeutic implications","volume":"19","author":"Xing","year":"2025","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1089\/neu.2020.7413","article-title":"Blood-spinal cord barrier in spinal cord injury: a review","volume":"38","author":"Jin","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14051556","article-title":"Multifaceted pathophysiology and secondary complications of chronic spinal cord injury: focus on pressure injury","volume":"14","author":"Mart\u00ednez-Torija","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib17","article-title":"Melatonin and Ischemic Stroke: Mechanistic Roles and Action","volume":"2015","author":"Andrabi","year":"2015","journal-title":"Adv. Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00018-022-04644-0","article-title":"Role of peripheral immune cells in spinal cord injury","volume":"80","author":"Li","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207533","article-title":"Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms","volume":"21","author":"Anjum","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00709-019-01439-2","article-title":"Ischemic stroke and mitochondria: mechanisms and targets","volume":"257","author":"Andrabi","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.biopha.2026.119389_bib21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s13311-018-0631-6","article-title":"Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory Responses","volume":"15","author":"Orr","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119389_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-021-02337-2","article-title":"Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration","volume":"18","author":"Hellenbrand","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.119389_bib23","article-title":"Exercise Impact on Cardiovascular Autonomic, Cerebrovascular, and Cognitive Dysfunction in Individuals With Spinal Cord Injury","author":"Ji","year":"2025","journal-title":"Arch. Phys. Med Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib24","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/j.2040-4603.2014.tb00584.x","article-title":"Autonomic consequences of spinal cord injury","volume":"4","author":"Hou","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.biopha.2026.119389_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative Stress: Harms and Benefits for Human Health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2026.119389_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1330678","article-title":"ROS: Executioner of regulating cell death in spinal cord injury","volume":"15","author":"Yin","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11091728","article-title":"3rd. Oxidative DNA Damage in the Pathophysiology of Spinal Cord Injury: Seems Obvious, but Where Is the Evidence?","volume":"11","author":"Scheijen","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119389_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00018-022-04261-x","article-title":"Mitochondrial function in spinal cord injury and regeneration","volume":"79","author":"Slater","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092290","article-title":"Rebuilding Mitochondrial Homeostasis and Inhibiting Ferroptosis: Therapeutic Mechanisms and Prospects for Spinal Cord Injury","volume":"13","author":"Wang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119389_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020408","article-title":"Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation","volume":"11","author":"Ashok","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119389_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/life13010009","article-title":"Molecular Mechanisms in the Vascular and Nervous Systems following Traumatic Spinal Cord Injury","volume":"13","author":"Li","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.biopha.2026.119389_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.22421","article-title":"The blood-spinal cord barrier: morphology and clinical implications","volume":"70","author":"Bartanusz","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.631500","article-title":"Revascularization After Traumatic Spinal Cord Injury","volume":"12","author":"Yao","year":"2021","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2026.119389_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52234-1","article-title":"Role of macrophages and activated microglia in neuropathic pain associated with chronic progressive spinal cord compression","volume":"9","author":"Takeura","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukaryotGeneExpr.2021039575","article-title":"Peptidomics Analysis Reveals Serum Biomarkers in Spinal Cord Injury Patients","volume":"32","author":"Zhao","year":"2022","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.biopha.2026.119389_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111779","article-title":"Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview","volume":"13","author":"Archie","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119389_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/neurosci3010001","article-title":"Blood-Spinal Cord Barrier: Its Role in Spinal Disorders and Emerging Therapeutic Strategies","volume":"3","author":"Chopra","year":"2022","journal-title":"NeuroSci"},{"key":"10.1016\/j.biopha.2026.119389_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1545968317746781","article-title":"Serum Albumin Predicts Long-Term Neurological Outcomes After Acute Spinal Cord Injury","volume":"32","author":"Tong","year":"2018","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.biopha.2026.119389_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s13311-011-0038-0","article-title":"Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury","volume":"8","author":"Zhang","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119389_bib40","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1523\/JNEUROSCI.22-17-07526.2002","article-title":"Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events","volume":"22","author":"Noble","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1386565","article-title":"Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury","volume":"15","author":"Xiong","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119389_bib42","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1007\/s00018-019-03176-4","article-title":"Matrix metalloproteinase signals following neurotrauma are right on cue","volume":"76","author":"Trivedi","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020268","article-title":"Metalloproteases in Pain Generation and Persistence: A Possible Target?","volume":"13","author":"Marcian\u00f2","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2026.119389_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043824","article-title":"Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury","volume":"24","author":"Khaing","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14072203","article-title":"Advances and New Therapies in Traumatic Spinal Cord Injury","volume":"14","author":"Montoto-Marqu\u00e9s","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sc.2008.176","article-title":"Biomarkers in spinal cord injury","volume":"47","author":"Pouw","year":"2009","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib47","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1089\/neu.2021.0264","article-title":"Serum levels of glial fibrillary acidic protein and neurofilament light protein are related to the neurological impairment and spinal edema after traumatic spinal cord injury","volume":"38","author":"Leister","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/neu.2022.0326","article-title":"Trajectory of serum levels of glial fibrillary acidic protein within four weeks post-injury is related to neurological recovery during the transition from acute to chronic spinal cord injury","volume":"40","author":"Leister","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib50","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/1538574418814612","article-title":"A systematic review of the use of biochemical markers in the assessment of spinal cord ischemia in thoracoabdominal aortic aneurysm repair","volume":"53","author":"Choong","year":"2019","journal-title":"Vasc. Endovasc. Surg."},{"key":"10.1016\/j.biopha.2026.119389_bib51","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1212\/WNL.0000000000206744","article-title":"Association of CSF and serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury","volume":"100","author":"Stukas","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2026.119389_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.biopha.2026.119389_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.873315","article-title":"Altered circulating immune cell distribution in traumatic spinal cord injury patients in relation to clinical parameters","volume":"13","author":"Fraussen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/jvim.15439","article-title":"Time course and prognostic value of serum GFAP, pNFH, and S100\u03b2 concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion","volume":"33","author":"Olby","year":"2019","journal-title":"J. Vet. Intern Med."},{"key":"10.1016\/j.biopha.2026.119389_bib55","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1089\/neu.2018.5675","article-title":"Increased Levels of Circulating Glial Fibrillary Acidic Protein and Collapsin Response Mediator Protein-2 Autoantibodies in the Acute Stage of Spinal Cord Injury Predict the Subsequent Development of Neuropathic Pain","volume":"35","author":"Hergenroeder","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052231","article-title":"Molecular biomarkers in neurological diseases: advances in diagnosis and prognosis","volume":"26","author":"Myrou","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib57","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4103\/1673-5374.324823","article-title":"Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.biopha.2026.119389_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11011-016-9801-6","article-title":"Neuron specific enolase: a promising therapeutic target in acute spinal cord injury","volume":"31","author":"Haque","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2026.119389_bib59","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s11064-017-2291-z","article-title":"Targeting enolase in reducing secondary damage in acute spinal cord injury in rats","volume":"42","author":"Haque","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2026.119389_bib60","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.12659\/MSM.907406","article-title":"The Prognostic Value of Serum Neuron Specific Enolase (NSE) and S100B Level in Patients of Acute Spinal Cord Injury","volume":"24","author":"Du","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2026.119389_bib61","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/glia.23994","article-title":"Implication of cerebral astrocytes in major depression: A review of fine neuroanatomical evidence in humans","volume":"69","author":"O'Leary","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.biopha.2026.119389_bib62","article-title":"Serum and Cerebrospinal Fluid Levels of S-100\u03b2 Is A Biomarker for Spinal Cord Injury; a Systematic Review and Meta-Analysis","volume":"7","author":"Faridaalee","year":"2019","journal-title":"Arch. Acad. Emerg. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib63","article-title":"Serum S100-Beta as a Biomarker for Neurological Recovery in Acute Spinal Cord Injury (ASCI): A Prospective Case-Control Study","volume":"17","author":"Waliullah","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2026.119389_bib64","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/s-0043-1771323","article-title":"The Accuracy of the S100B Protein Biomarker in the Prognosis of Patients with Acute Spinal Cord Injury","volume":"19","author":"Haddadi","year":"2024","journal-title":"Asian J. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119389_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/emj.2008.063743","article-title":"Elevated serum S100B levels in acute spinal fracture without head injury","volume":"27","author":"Lee","year":"2010","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.biopha.2026.119389_bib66","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1042\/BCJ20160082","article-title":"Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction","volume":"473","author":"Bishop","year":"2016","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2026.119389_bib67","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.2147\/IJGM.S364736","article-title":"Circulating Ubiquitin Carboxyl Terminal Hydrolase L1 and Neuroglobin Levels in Traumatic Spinal Cord Injuries: Relation to Severity and Outcomes","volume":"15","author":"Abuhamdah","year":"2022","journal-title":"Int J. Gen. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib68","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00701-020-04422-6","article-title":"Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration","volume":"162","author":"Holmstr\u00f6m","year":"2020","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.biopha.2026.119389_bib69","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.wneu.2013.03.012","article-title":"Acute diagnostic biomarkers for spinal cord injury: review of the literature and preliminary research report","volume":"83","author":"Yokobori","year":"2015","journal-title":"World Neurosurg."},{"key":"10.1016\/j.biopha.2026.119389_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fneur.2019.00027","article-title":"Biomarkers in Spinal Cord Injury: Prognostic Insights and Future Potentials","volume":"10","author":"Albayar","year":"2019","journal-title":"Front Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2011.06.006","article-title":"Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity","volume":"235","author":"Akbik","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s12031-020-01679-5","article-title":"Microtubule Stabilization Promotes Microcirculation Reconstruction After Spinal Cord Injury","volume":"71","author":"Duan","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib73","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1460-9568.1997.tb01497.x","article-title":"Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study","volume":"9","author":"Bartholdi","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157249","article-title":"Spinal Cord Injury Remyelination: Pathways to Therapies","volume":"26","author":"Kaniuk","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib75","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib76","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/neu.2016.4435","article-title":"Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury","volume":"34","author":"Kwon","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib77","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1006\/nbdi.2000.0318","article-title":"Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia\/macrophages after spinal cord injury","volume":"7","author":"Dougherty","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2026.119389_bib78","article-title":"The role of immune cells and associated immunological factors in the immune response to spinal cord injury","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11030322","article-title":"Blood Serum Cytokines in Patients with Subacute Spinal Cord Injury: A Pilot Study to Search for Biomarkers of Injury Severity","volume":"11","author":"Ogurcov","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1619337","article-title":"Regulatory effect of inflammatory mediators in spinal cord injury","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172692","article-title":"Inflammation: A Target for Treatment in Spinal Cord Injury","volume":"11","author":"Freyermuth-Trujillo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119389_bib82","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00109-005-0663-3","article-title":"Molecular targets in spinal cord injury","volume":"83","author":"Klussmann","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s10571-022-01229-0","article-title":"The Role of Tumor Necrosis Factor Following Spinal Cord Injury: A Systematic Review","volume":"43","author":"Lund","year":"2023","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119389_bib84","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.imbio.2012.05.007","article-title":"Late blocking of peripheral TNF-\u03b1 is ineffective after spinal cord injury in mice","volume":"218","author":"Vidal","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2026.119389_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26199624","article-title":"Immune Activation Following Spinal Cord Injury: A Review Focused on Inflammatory Changes in the Spinal Cord","volume":"26","author":"Nascimento","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib86","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbi.2025.05.024","article-title":"Long-term dynamics of the spinal cord injury neuroinflammatory response and sensory dysfunction in female mice","volume":"129","author":"Wrobel","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.biopha.2026.119389_bib87","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1545968319899920","article-title":"Biomarkers in Traumatic Spinal Cord Injury-Technical and Clinical Considerations: A Systematic Review","volume":"34","author":"Leister","year":"2020","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.biopha.2026.119389_bib88","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/sc.2015.28","article-title":"A pilot study on temporal changes in IL-1\u03b2 and TNF-\u03b1 serum levels after spinal cord injury: the serum level of TNF-\u03b1 in acute SCI patients as a possible marker for neurological remission","volume":"53","author":"Biglari","year":"2015","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib89","article-title":"Immune response following traumatic spinal cord injury: Pathophysiology and therapies","volume":"13","author":"Sterner","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221834","article-title":"The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases","volume":"13","author":"Ghosh","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119389_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1670650","article-title":"Neuroinflammation: targeting microglia for neuroprotection and repair after spinal cord injury","volume":"16","author":"Cavalcanti","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib92","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1007\/s10787-025-01952-2","article-title":"The neuroinflammatory triumvirate: NF-\u03baB, NLRP3, and mTOR in spinal cord injury","volume":"33","author":"Darabniya","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.biopha.2026.119389_bib93","article-title":"Interaction between neurons and microglia in healthy and disease states","author":"Nakamura","year":"2025","journal-title":"Int Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib94","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2025.10630","article-title":"Spinal Cord Injury and Ageing: The Role of Chronic Neuroinflammation","author":"Wang","year":"2025","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2026.119389_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05382.x","article-title":"An overview of cytokines and cytokine antagonists as therapeutic agents","volume":"1182","author":"Donnelly","year":"2009","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib96","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s11033-025-10785-9","article-title":"Pathophysiology of spinal cord injury and advanced therapeutic approaches","volume":"52","author":"Yadav","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115039","article-title":"No impact of anti-inflammatory medication on inflammation-driven recovery following cervical spinal cord injury in rats","volume":"383","author":"Cucarian","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib98","doi-asserted-by":"crossref","DOI":"10.17305\/bb.2025.13147","article-title":"Advancing regenerative therapies with umbilical cord-derived mesenchymal stem cells: A review","author":"Hussein","year":"2025","journal-title":"Biomol. Biomed."},{"key":"10.1016\/j.biopha.2026.119389_bib99","doi-asserted-by":"crossref","DOI":"10.4252\/wjsc.v17.i7.107212","article-title":"Therapeutic strategies for intervertebral disc degeneration: Extracellular vesicles and microRNAs derived from mesenchymal stem cells","volume":"17","author":"Lim","year":"2025","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.biopha.2026.119389_bib100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/hum.2023.210","article-title":"The New Frontiers of Gene Therapy and Gene Editing in Inflammatory Diseases","volume":"35","author":"Romano","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biopha.2026.119389_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2025.1569289","article-title":"Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation","volume":"16","author":"Raghavan","year":"2025","journal-title":"Front Genet"},{"key":"10.1016\/j.biopha.2026.119389_bib102","article-title":"Spatial distribution-based progression of spinal cord injury pathology: a key role for neuroimmune cells","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib103","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.049856","article-title":"Infiltrating circulating monocytes provide an important source of BMP4 at the early stage of spinal cord injury","volume":"16","author":"Shen","year":"2023","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2026.119389_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911496","article-title":"Acute Systemic White Blood Cell Changes following Degenerative Cervical Myelopathy (DCM) in a Mouse Model","volume":"23","author":"Ulndreaj","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib105","article-title":"Identification of immunodiagnostic blood biomarkers associated with spinal cord injury severity","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib106","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1326-7-6","article-title":"Spinal cord trauma and the molecular point of no return","volume":"7","author":"Yip","year":"2012","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.biopha.2026.119389_bib107","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/WCO.0000000000000995","article-title":"Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury","volume":"34","author":"Jogia","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.648076","article-title":"For Better or for Worse: A Look Into Neutrophils in Traumatic Spinal Cord Injury","volume":"15","author":"Zivkovic","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.abb.2018.01.004","article-title":"Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function","volume":"640","author":"Aratani","year":"2018","journal-title":"Arch. Biochem Biophys."},{"key":"10.1016\/j.biopha.2026.119389_bib110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/BRS.0b013e31824b9e77","article-title":"Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury","volume":"37","author":"Kubota","year":"2012","journal-title":"Spine"},{"key":"10.1016\/j.biopha.2026.119389_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/medicina60101567","article-title":"The Neutrophil-to-Lymphocyte Ratio in Patients with Spinal Cord Injury: A Narrative Review Study","volume":"60","author":"Naseri Alavi","year":"2024","journal-title":"Medicina"},{"key":"10.1016\/j.biopha.2026.119389_bib112","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1093\/brain\/awl296","article-title":"The cellular inflammatory response in human spinal cords after injury","volume":"129","author":"Fleming","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119389_bib113","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1016\/j.wneu.2024.07.204","article-title":"Prognostic Value of Magnetic Resonance Imaging Variables Combined with Neutrophil-to-Lymphocyte Ratio in Patients with Cervical Traumatic Spinal Cord Injury","volume":"190","author":"Liu","year":"2024","journal-title":"World Neurosurg."},{"key":"10.1016\/j.biopha.2026.119389_bib114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41393-023-00949-4","article-title":"Neutrophil-to-lymphocyte ratio at admission for early diagnosis, severity assessment, and prognosis of acute traumatic spinal cord injury","volume":"62","author":"Chen","year":"2024","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.46292\/sci24-00068","article-title":"Different Circulating Endothelial Microvesicle Subtype Signature in Subacute and Chronic Spinal Cord Injury","volume":"31","author":"Park","year":"2025","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib116","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020744","article-title":"Systemic Inflammation and the Breakdown of Intestinal Homeostasis Are Key Events in Chronic Spinal Cord Injury Patients","volume":"22","author":"Diaz","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib117","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00401-019-01992-3","article-title":"The origin, fate, and contribution of macrophages to spinal cord injury pathology","volume":"137","author":"Milich","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119389_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1495801","article-title":"Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression","volume":"15","author":"Coenen","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.119389_bib119","article-title":"The emerging role of exosomes in communication between the periphery and the central nervous system","volume":"4","author":"Han","year":"2023","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.biopha.2026.119389_bib120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2020.00038","article-title":"CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges","volume":"13","author":"Hornung","year":"2020","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib121","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27042079","article-title":"Extracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances","volume":"27","author":"Vo","year":"2026","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib122","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/1535370219872759","article-title":"Identification of serum exosomal microRNAs in acute spinal cord injured rats","volume":"244","author":"Ding","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib123","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.ygeno.2019.12.003","article-title":"Serum exosomal microRNA transcriptome profiling in subacute spinal cord injured rats","volume":"112","author":"Ding","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.biopha.2026.119389_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.703989","article-title":"Emerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury","volume":"9","author":"Feng","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2026.119389_bib125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41394-023-00590-6","article-title":"Acute changes in antioxidants and oxidative stress to vigorous arm exercise: an intervention trial in persons with spinal cord injury and healthy controls","volume":"9","author":"Wouda","year":"2023","journal-title":"Spinal Cord. Ser. Cases"},{"key":"10.1016\/j.biopha.2026.119389_bib126","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.apmr.2012.06.021","article-title":"Reduced antioxidant defense and increased oxidative stress in spinal cord injured patients","volume":"93","author":"Bastani","year":"2012","journal-title":"Arch. Phys. Med Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib127","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/10790268.2016.1228286","article-title":"The analysis of serum lipid levels in patients with spinal cord injury","volume":"40","author":"Koyuncu","year":"2017","journal-title":"J. Spinal Cord. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib128","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s11033-025-11091-0","article-title":"Disruptions in nitric oxide homeostasis, lipid peroxidation-derived oxidative stress, and antioxidant defense mechanisms in spinal cord injury: elucidating biomolecular correlates of disease severity","volume":"52","author":"Mursal","year":"2025","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14091081","article-title":"A Review of the Potential Use of Antioxidants in Spinal Cord Injuries","volume":"14","author":"Nowacka","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119389_bib130","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.4103\/1673-5374.301487","article-title":"Identification of potential oxidative stress biomarkers for spinal cord injury in erythrocytes using mass spectrometry","volume":"16","author":"Zhang","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119389_bib131","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-023-01477-6","article-title":"Spinal cord injury: molecular mechanisms and therapeutic interventions","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119389_bib132","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201795","article-title":"Diagnostic blood RNA profiles for human acute spinal cord injury","volume":"218","author":"Kyritsis","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib133","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/1354750X.2023.2298650","article-title":"A future blood test for acute traumatic spinal cord injury","volume":"28","author":"Azad","year":"2023","journal-title":"Biomarkers"},{"key":"10.1016\/j.biopha.2026.119389_bib134","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1089\/neu.2017.5519","article-title":"Persons with Chronic Spinal Cord Injury Have Decreased Natural Killer Cell and Increased Toll-Like Receptor\/Inflammatory Gene Expression","volume":"35","author":"Herman","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib135","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12967-024-06009-6","article-title":"A comprehensive transcriptional reference for severity and progression in spinal cord injury reveals novel translational biomarker genes","volume":"23","author":"Grillo-Risco","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117306","article-title":"Epigenetic modifications of inflammation in spinal cord injury","volume":"179","author":"Lu","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.119389_bib137","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13311-013-0228-z","article-title":"Epigenetics of neural repair following spinal cord injury","volume":"10","author":"York","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.biopha.2026.119389_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021503","article-title":"Cell-Free DNA Fragmentomics: The Novel Promising Biomarker","volume":"24","author":"Qi","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185463","article-title":"A multi-analyte blood test for acute spinal cord injury","volume":"135","author":"Azad","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119389_bib140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12031-025-02317-8","article-title":"The Potential of cfDNA as Biomarker: Opportunities and Challenges for Neurodegenerative Diseases","volume":"75","author":"Ayd\u0131n","year":"2025","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib141","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26167895","article-title":"A Review of Pathophysiology, Molecular Mechanisms, and Omics Approaches of Spinal Cord Injury","volume":"26","author":"Patel","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib142","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41746-025-01782-0","article-title":"Modeling trajectories of routine blood tests as dynamic biomarkers for outcome in spinal cord injury","volume":"8","author":"Mussavi Rizi","year":"2025","journal-title":"NPJ Digit Med."},{"key":"10.1016\/j.biopha.2026.119389_bib143","article-title":"Biomarkers, and Therapeutic Modalities Associated with Skeletal Muscle Loss Following Spinal Cord Injury","volume":"10","author":"K","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib144","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/1673-5374.202933","article-title":"The translational importance of establishing biomarkers of human spinal cord injury","volume":"12","author":"Elizei","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.biopha.2026.119389_bib145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1212\/CON.0000000000001423","article-title":"Traumatic Brain Injury and Traumatic Spinal Cord Injury","volume":"30","author":"Podell","year":"2024","journal-title":"Continuum"},{"key":"10.1016\/j.biopha.2026.119389_bib146","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s12967-024-05344-y","article-title":"Untargeted blood serum proteomics identifies novel proteins related to neurological recovery after human spinal cord injury","volume":"22","author":"Garcia-Ovejero","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146864","article-title":"The Utility of Metabolomics in Spinal Cord Injury: Opportunities for Biomarker Discovery and Neuroprotection","volume":"26","author":"Zilundu","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061630","article-title":"Biomarkers as Biomedical Bioindicators: Approaches and Techniques for the Detection, Analysis, and Validation of Novel Biomarkers of Diseases","volume":"15","author":"Ahmad","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119389_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2026.115649","article-title":"Machine learning for discovery of clinical pain biomarkers following spinal cord injury","volume":"398","author":"Florea","year":"2026","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib150","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-93006-4","article-title":"Research on multi-algorithm and explainable AI techniques for predictive modeling of acute spinal cord injury using multimodal data","volume":"15","author":"Tai","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib151","doi-asserted-by":"crossref","DOI":"10.2196\/66233","article-title":"Predicting Spinal Cord Injury Prognosis Using Machine Learning: Systematic Review and Meta-Analysis","volume":"4","author":"Zhong","year":"2025","journal-title":"Jmir ai"},{"key":"10.1016\/j.biopha.2026.119389_bib152","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4103\/1673-5374.391306","article-title":"Screening biomarkers for spinal cord injury using weighted gene co-expression network analysis and machine learning","volume":"19","author":"Li","year":"2024","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.biopha.2026.119389_bib153","first-page":"737","article-title":"Convolutional Neural Network-Based Automated Segmentation of the Spinal Cord and Contusion Injury: Deep Learning Biomarker Correlates of Motor Impairment in Acute Spinal Cord Injury","volume":"40","author":"McCoy","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.biopha.2026.119389_bib154","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0149-22.2022","article-title":"Spinal Cord Injury AIS Predictions Using Machine Learning","volume":"10","author":"Kapoor","year":"2023","journal-title":"eNeuro"},{"key":"10.1016\/j.biopha.2026.119389_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1622787","article-title":"Targeting ferroptosis in spinal cord injury through stem cell therapy: mechanisms and therapeutic prospects","volume":"19","author":"Shen","year":"2025","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1592297","article-title":"Research progress on the mechanisms of endogenous neural stem cell differentiation in spinal cord injury repair","volume":"19","author":"Wang","year":"2025","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib157","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20220017","article-title":"Current treatments after spinal cord injury: Cell engineering, tissue engineering, and combined therapies","volume":"1","author":"Shen","year":"2022","journal-title":"Smart Med"},{"key":"10.1016\/j.biopha.2026.119389_bib158","doi-asserted-by":"crossref","DOI":"10.1007\/s13770-025-00757-2","article-title":"Clinical Efficacy of Stem Cell Therapy in Neurotraumatic and Neurodegenerative Conditions: A Comparative Review","author":"Ku","year":"2025","journal-title":"Tissue Eng. Regen. Med"},{"key":"10.1016\/j.biopha.2026.119389_bib159","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1021\/acsabm.5c00459","article-title":"Advancements in Spinal Cord Injury Treatment: Integrating Drug Delivery, Biophysical Stimulation, Cell-Based Therapies, and Tissue Engineering Approaches","volume":"8","author":"Bhatt","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.biopha.2026.119389_bib160","doi-asserted-by":"crossref","DOI":"10.25259\/SNI_678_2025","article-title":"Evaluating the role of surgical timing on clinical outcomes in traumatic spinal cord injury: A systematic review and meta-analysis","volume":"16","author":"Nazwar","year":"2025","journal-title":"Surg. Neurol. Int"},{"key":"10.1016\/j.biopha.2026.119389_bib161","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000001434","article-title":"Riluzole as a pharmacological therapy for spinal cord injury: where does this therapy stand?","author":"Pedro","year":"2025","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib162","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/BSD.0000000000001695","article-title":"Pharmacologic Therapy for Spinal Cord Injury","volume":"37","author":"Sherrod","year":"2024","journal-title":"Clin. Spine Surg."},{"key":"10.1016\/j.biopha.2026.119389_bib163","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13287-024-03825-x","article-title":"The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2026.119389_bib164","article-title":"Current Concepts of Neural Stem\/Progenitor Cell Therapy for Chronic Spinal Cord Injury","volume":"15","author":"Suzuki","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147435","article-title":"Current Concepts of Stem Cell Therapy for Chronic Spinal Cord Injury","volume":"22","author":"Suzuki","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032528","article-title":"Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury","volume":"24","author":"Suzuki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib167","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.pbr.2020.09.007","article-title":"Spinal cord stimulation and intrathecal baclofen therapy for patients with severe spasticity after spinal cord injury","volume":"258","author":"Biktimirov","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.biopha.2026.119389_bib168","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s13760-024-02524-x","article-title":"Long-term use of intrathecal baclofen reduces neuropathic pain and its interference with general activity in spinal cord injury individuals","volume":"124","author":"Kumru","year":"2024","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.biopha.2026.119389_bib169","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/ten.teb.2019.0182","article-title":"Regenerative Therapies for Spinal Cord Injury","volume":"25","author":"Ashammakhi","year":"2019","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.biopha.2026.119389_bib170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.46292\/sci23-00044S","article-title":"Challenges in Translating Regenerative Therapies for Spinal Cord Injury","volume":"29","author":"Stewart","year":"2023","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib171","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/ten.tec.2025.0032","article-title":"Guide for Cell Therapy in Human Chronic Spinal Cord Injury","volume":"31","author":"Abolghasemi","year":"2025","journal-title":"Tissue Eng. Part C. Methods"},{"key":"10.1016\/j.biopha.2026.119389_bib172","article-title":"Long-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury","volume":"5","author":"Martin","year":"2024","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.biopha.2026.119389_bib173","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11427-021-1985-5","article-title":"Long-term clinical observation of patients with acute and chronic complete spinal cord injury after transplantation of NeuroRegen scaffold","volume":"65","author":"Tang","year":"2022","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119558","article-title":"Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis","volume":"227","author":"Vijayaraghavalu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2026.119389_bib175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41394-020-00345-7","article-title":"Spinal cord stimulation and rehabilitation in an individual with chronic complete L1 paraplegia due to a conus medullaris injury: motor and functional outcomes at 18 months","volume":"6","author":"Krucoff","year":"2020","journal-title":"Spinal Cord. Ser. Cases"},{"key":"10.1016\/j.biopha.2026.119389_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinph.2025.2111372","article-title":"Timing-dependent synergies between noninvasive motor cortex and spinal cord stimulation in chronic cervical spinal cord injury","volume":"180","author":"Murray","year":"2025","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.biopha.2026.119389_bib177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46292\/sci24-00076","article-title":"Exploring the Landscape of Biomarkers in Spinal Cord Injury","volume":"31","author":"Scheuren","year":"2025","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib178","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1093\/neuros\/nyaa149","article-title":"Cell Therapies for Spinal Cord Injury: Trends and Challenges of Current Clinical Trials","volume":"87","author":"Bartlett","year":"2020","journal-title":"Neurosurgery"},{"key":"10.1016\/j.biopha.2026.119389_bib179","doi-asserted-by":"crossref","DOI":"10.1177\/08977151251371710","article-title":"Combining Therapeutic Strategies to Treat the Injured Spinal Cord: A Translational Perspective","author":"Sherman","year":"2025","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/neur.2023.0114","article-title":"Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses","volume":"5","author":"Weisbrod","year":"2024","journal-title":"Neurotrauma Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19350","article-title":"Efficacy of combination of N-acetylcysteine and primrose in spinal cord injury; an experimental study","volume":"9","author":"\u00c7avu\u015f","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2026.119389_bib182","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.1523\/JNEUROSCI.1661-07.2007","article-title":"Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury","volume":"27","author":"Yune","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14010017","article-title":"Advancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches","volume":"14","author":"Shen","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2026.119389_bib184","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1186\/s12967-025-06974-6","article-title":"Biomaterials and cell-based therapy post spinal cord injury","volume":"23","author":"Haratizadeh","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s43856-024-00638-0","article-title":"Impact of commonly administered drugs on the progression of spinal cord injury: a systematic review","volume":"4","author":"Bourguignon","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib186","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11910-017-0736-z","article-title":"The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries","volume":"17","author":"Sarkis","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib187","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s12035-016-9757-x","article-title":"The Next Generation of Biomarker Research in Spinal Cord Injury","volume":"54","author":"Ydens","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119389_bib188","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1002\/sim.5403","article-title":"Biomarkers and surrogate endpoints in clinical trials","volume":"31","author":"Fleming","year":"2012","journal-title":"Stat. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib189","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sc.2016.174","article-title":"The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood","volume":"55","author":"Hulme","year":"2017","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib190","article-title":"Biofluid Biomarkers of Acute Traumatic Spinal Cord Injury: A Systematic Review","author":"Schaeffer","year":"2025","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13101814","article-title":"Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury","volume":"13","author":"Yang","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.biopha.2026.119389_bib192","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1089\/neu.2020.7352","article-title":"Characterization of Cerebrospinal Fluid Ubiquitin C-Terminal Hydrolase L1 as a Biomarker of Human Acute Traumatic Spinal Cord Injury","volume":"38","author":"Stukas","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.biopha.2026.119389_bib193","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2015.04.004","article-title":"Tumor necrosis factor-alpha is a potential diagnostic biomarker for chronic neuropathic pain after spinal cord injury","volume":"595","author":"Xu","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2026.119389_bib194","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sc.2016.104","article-title":"Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury","volume":"55","author":"Moghaddam","year":"2017","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib195","first-page":"188","article-title":"Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing","volume":"99","author":"Goussev","year":"2003","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.biopha.2026.119389_bib196","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3340\/jkns.2011.50.4.288","article-title":"Activation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats","volume":"50","author":"Jang","year":"2011","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.biopha.2026.119389_bib197","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.3390\/ijms16047900","article-title":"Posttraumatic inflammation as a key to neuroregeneration after traumatic spinal cord injury","volume":"16","author":"Moghaddam","year":"2015","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib198","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3390\/cimb44020040","article-title":"Mesenchymal Stem Cells in the Treatment of Human Spinal Cord Injury: The Effect on Individual Values of pNF-H, GFAP, S100 Proteins and Selected Growth Factors, Cytokines and Chemokines","volume":"44","author":"Slovinska","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.biopha.2026.119389_bib199","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13040626","article-title":"Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury","volume":"13","author":"Haro Gir\u00f3n","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib200","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00701-023-05520-x","article-title":"Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study","volume":"165","author":"Wichmann","year":"2023","journal-title":"Acta Neurochir."},{"key":"10.1016\/j.biopha.2026.119389_bib201","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.4103\/neurol-india.Neurol-India-D-25-00605","article-title":"Diagnostic and Prognostic Significance of Serum Biomarkers in Traumatic Spinal Cord Injury: A Prospective Cohort Study","volume":"73","author":"Raheja","year":"2025","journal-title":"Neurol. India"},{"key":"10.1016\/j.biopha.2026.119389_bib202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2019.12.001","article-title":"Nanoparticles with antioxidant enzymes protect injured spinal cord from neuronal cell apoptosis by attenuating mitochondrial dysfunction","volume":"317","author":"Andrabi","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119389_bib203","article-title":"The Translation of Nanomedicines in the Contexts of Spinal Cord Injury and Repair","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2026.119389_bib204","first-page":"1145","article-title":"Methylprednisolone for acute spinal cord injury: not a standard of care","volume":"168","author":"Hugenholtz","year":"2003","journal-title":"Cmaj"},{"key":"10.1016\/j.biopha.2026.119389_bib205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.08.060","article-title":"Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injury","volume":"219","author":"Kabu","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119389_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13092176","article-title":"What Is New in Spinal Cord Injury Management: A Narrative Review on the Emerging Role of Nanotechnology","volume":"13","author":"Raciti","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2026.119389_bib207","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2019.03.026","article-title":"Evaluating accessibility of intravenously administered nanoparticles at the lesion site in rat and pig contusion models of spinal cord injury","volume":"302","author":"Gao","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119389_bib208","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jconrel.2023.10.028","article-title":"Catalytic antioxidant nanoparticles mitigate secondary injury progression and promote functional recovery in spinal cord injury model","volume":"364","author":"Jaffer","year":"2023","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2026.119389_bib209","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41393-019-0319-8","article-title":"Neurochemical biomarkers in spinal cord injury","volume":"57","author":"Kwon","year":"2019","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib210","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.977679","article-title":"Fighting for recovery on multiple fronts: The past, present, and future of clinical trials for spinal cord injury","volume":"16","author":"Dietz","year":"2022","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.119389_bib211","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113925","article-title":"Recruitment Challenges in Spinal Cord Stimulation Trial for Motor Recovery in Patients with Chronic Complete Spinal Cord Injury","volume":"14","author":"Misbaah","year":"2025","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2026.119389_bib212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.46292\/sci20-00070","article-title":"An Assessment of Which Sociodemographic and Spinal Cord Injury-Specific Characteristics Influence Engagement With Experimental Therapies and Participation in Clinical Trials","volume":"27","author":"Pazzi","year":"2021","journal-title":"Top. Spinal Cord. Inj. Rehabil."},{"key":"10.1016\/j.biopha.2026.119389_bib213","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41393-023-00934-x","article-title":"Minimal clinically important difference (MCID) and minimal detectable change (MDC) of Spinal Cord Ability Ruler (SCAR)","volume":"61","author":"Chaidaroon","year":"2023","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib214","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1682\/JRRD.2005.07.0123","article-title":"Spinal Cord Independence Measure: comprehensive ability rating scale for the spinal cord lesion patient","volume":"44","author":"Catz","year":"2007","journal-title":"J. Rehabil. Res Dev."},{"key":"10.1016\/j.biopha.2026.119389_bib215","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/10543406.2020.1832110","article-title":"Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment","volume":"30","author":"Wang","year":"2020","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.biopha.2026.119389_bib216","doi-asserted-by":"crossref","DOI":"10.1002\/sim.70275","article-title":"Adaptive Biomarker-Based Design for Early Phase Clinical Trials","volume":"44","author":"Serra","year":"2025","journal-title":"Stat. Med"},{"key":"10.1016\/j.biopha.2026.119389_bib217","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/neuonc\/noae186","article-title":"Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions","volume":"27","author":"Lim-Fat","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2026.119389_bib218","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(24)00447-2","article-title":"Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trial","volume":"24","author":"Weidner","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib219","article-title":"Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases","volume":"25","author":"Park","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12245-025-00932-1","article-title":"Neuron-specific enolase: a potential biomarker in the prediction of pediatric head trauma outcomes: a systematic review and meta-analysis","volume":"18","author":"Behforouz","year":"2025","journal-title":"Int J. Emerg. Med"},{"key":"10.1016\/j.biopha.2026.119389_bib221","doi-asserted-by":"crossref","first-page":"896","DOI":"10.4103\/1673-5374.249238","article-title":"Serum and cerebrospinal fluid tau protein level as biomarkers for evaluating acute spinal cord injury severity and motor function outcome","volume":"14","author":"Tang","year":"2019","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.biopha.2026.119389_bib222","doi-asserted-by":"crossref","DOI":"10.3171\/2020.2.FOCUS191030","article-title":"Transforming Research and Clinical Knowledge in Spinal Cord Injury (TRACK-SCI): an overview of initial enrollment and demographics","volume":"48","author":"Tsolinas","year":"2020","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.biopha.2026.119389_bib223","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41393-020-00547-8","article-title":"Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous system","volume":"58","author":"Mulcahey","year":"2020","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib224","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1055\/s-0039-1698032","article-title":"Spinal Cord Injury: Point-of-Care Biomarkers for Better Prognosis","volume":"10","author":"Ghosh","year":"2019","journal-title":"J. Neurosci. Rural Pr."},{"key":"10.1016\/j.biopha.2026.119389_bib225","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s12015-025-10966-w","article-title":"Spinal Cord Injury 2.0: Bridging the Gap Between Neurobiology, Technology, and Hope in the Era of Precision Medicine","volume":"21","author":"Wang","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib226","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.irn.2024.10.009","article-title":"Exploring neuroinflammation: A key driver in neuropathic pain disorders","volume":"179","author":"Scheuren","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119389_bib227","article-title":"Enhanced clinical trial stratification in spinal cord injury: the value of electrophysiology","author":"Scheuren","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119389_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105381","article-title":"Next-gen spinal cord injury clinical trials: lessons learned and opportunities for future success","volume":"109","author":"Scheuren","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2026.119389_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100096","article-title":"Proteomic Portraits Reveal Evolutionarily Conserved and Divergent Responses to Spinal Cord Injury","volume":"20","author":"Skinnider","year":"2021","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.biopha.2026.119389_bib230","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70028","article-title":"Re-Innovation in Clinical Trial Designs Based on Precision Therapy","volume":"4","author":"Li","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.biopha.2026.119389_bib231","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-024-04846-5","article-title":"Clinical trial design for novel targeted agents in neuro-oncology","volume":"171","author":"Lim-Fat","year":"2025","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.biopha.2026.119389_bib232","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70377","article-title":"Use of Biomarkers in Drug Development for Regulatory Purposes","volume":"18","author":"Schuck","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib233","first-page":"929","article-title":"Current landscape of US Food and Drug Administration use of expedited regulatory approvals for colorectal cancer care","volume":"31","author":"Horn","year":"2025","journal-title":"J. Manag Care Spec. Pharm."},{"key":"10.1016\/j.biopha.2026.119389_bib234","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00228-025-03822-w","article-title":"Era of surrogate endpoints and accelerated approvals: a comprehensive review on applicability, uncertainties, and challenges from regulatory, payer, and patient perspectives","volume":"81","author":"Sharma","year":"2025","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2026.119389_bib235","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1038\/s41598-017-07358-7","article-title":"Evidence for Treatment-by-Biomarker interaction for FDA-approved Oncology Drugs with Required Pharmacogenomic Biomarker Testing","volume":"7","author":"Vivot","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib236","first-page":"907","article-title":"Donanemab, an Amyloid \u03b2-targeting Antibody for Early Symptomatic Alzheimer's Disease: Summary of Clinical Study Results]","volume":"77","author":"Sato","year":"2025","journal-title":"Brain Nerve"},{"key":"10.1016\/j.biopha.2026.119389_bib237","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cpt.3661","article-title":"Participants in the FDA's Biomarker Qualification Program","volume":"118","author":"Shahzad","year":"2025","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.biopha.2026.119389_bib238","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ana.26860","article-title":"Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice","volume":"95","author":"Benatar","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib239","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","article-title":"The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology","volume":"20","author":"Cagney","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biopha.2026.119389_bib240","article-title":"FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2026.119389_bib241","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.3389\/fpubh.2017.00307","article-title":"Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice","volume":"5","author":"Trevethan","year":"2017","journal-title":"Front. Public Health"},{"key":"10.1016\/j.biopha.2026.119389_bib242","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11845-023-03476-6","article-title":"Prognosticating acute traumatic spinal cord injury using Neurofilament (NF), Neuron Specific Enolase (NSE), Matrix Metalloproteinases (MMPs), and S-100B as biomarkers","volume":"193","author":"Paragond","year":"2024","journal-title":"Ir. J. Med Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib243","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/jnr.25120","article-title":"Animal models of compression spinal cord injury","volume":"100","author":"Ridlen","year":"2022","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.biopha.2026.119389_bib244","doi-asserted-by":"crossref","DOI":"10.3389\/ebm.2024.10266","article-title":"Bridging the gap: a translational perspective in spinal cord injury","volume":"249","author":"Hassan","year":"2024","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.biopha.2026.119389_bib245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cts.12449","article-title":"Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker Research","volume":"10","author":"McShane","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib246","article-title":"Spinal cord injury models: Advantages and disadvantages in the view of pathophysiology and clinical significance","volume":"42","author":"Li","year":"2025","journal-title":"Biochem Biophys. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib247","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1177\/21925682251350941","article-title":"AO Spine Clinical Practice Recommendations for the Surgical Management of Acute Traumatic Spinal Cord Injury: Contemporary Concepts","volume":"15","author":"Hubertus","year":"2025","journal-title":"Glob. Spine J."},{"key":"10.1016\/j.biopha.2026.119389_bib248","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12883-024-03980-x","article-title":"A research protocol to study the critical time window for rehabilitation after incomplete spinal cord injury: early vs. late locomotor training","volume":"24","author":"Henry","year":"2024","journal-title":"BMC Neurol."},{"key":"10.1016\/j.biopha.2026.119389_bib249","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41393-025-01094-w","article-title":"Challenges and strategies for spinal cord injury research recruitment in rehabilitation hospitals: a single center perspective","volume":"63","author":"Kirshblum","year":"2025","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.119389_bib250","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.119389_bib251","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11910-021-01134-x","article-title":"Improving diagnostic workup following traumatic spinal cord injury: advances in biomarkers","volume":"21","author":"Schading","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biopha.2026.119389_bib252","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239037","article-title":"Early CSF Biomarkers and Late Functional Outcomes in Spinal Cord Injury. A Pilot Study","volume":"21","author":"Capirossi","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119389_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102303","article-title":"Systemic inflammation after spinal cord injury: a review of biological evidence, related health risks, and potential therapies","volume":"67","author":"Bigford","year":"2022","journal-title":"Curr. Opin. Pharm."},{"key":"10.1016\/j.biopha.2026.119389_bib254","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27103194","article-title":"Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases","volume":"27","author":"Rauf","year":"2022","journal-title":"Molecules"}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119924","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000}},{"DOI":"10.1016\/j.biopha.2026.119924","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226004245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:50:40Z","timestamp":1794477040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226004245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":254,"alternative-id":["S0753332226004245"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119389","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving role of biomarkers in spinal cord injury: From research to clinical translation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119389"}}